The proposed districts in this phase are Sanitpur, Golghat, Jorhat, Sivasagar, Dibrugarh, Tinsukia in Assam, Wayanad in Kerala and Kutch district in Gujarat, starting from September 2022 and ending by August 2023.
Fujifilm India has launched the second phase of its TB campaign ‘Never Stop: Screening to Reduce Diagnosis Delays’. The second phase of this campaign aims to raise awareness of TB as a curable disease and promote screening and early diagnosis among tea sector workers, hard-to-reach populations in rural and urban areas, including tribal populations in selected areas of Gujarat, Kerala and Assam. As part of the campaign, Fujifilm India will support three mobile hand-held X-ray machines and the implementation of the project in a community setting
Fujifilm aims to reach more than 5 million people and screen about 30,000 of them with portable X-ray machines. The project will also facilitate TB testing of identified suspected cases. In cooperation with the International Union against Tuberculosis and Lung Disease (Union) the project aims to demonstrate a model of promoting early diagnosis of tuberculosis by using new solutions in community settings. Through this campaign, Fujifilm will offer door-to-door TB awareness and mobile digital X-ray services alongside Qure.ai, an automated radiology software application designed with deep learning for intervention.
The proposed districts in this phase are Sanitpur, Golghat, Jorhat, Sivasagar, Dibrugarh, Tinsukia in Assam, Wayanad in Kerala and Kutch district in Gujarat, starting from September 2022 and ending by August 2023.
In the first phase, Fujifilm India screened over a million people and shared around 8,000 X-ray reports. As a result of the intervention, 117 new TB cases were detected in 27 cities including Delhi, Dadri, Dehradun, Haridwar, Haldwani, Rudrapur, Patna, Jaipur, Indore, Kolkata, Raipur, Patta, etc.